Antibiotic Duration After Laparoscopic Appendectomy for Acute Complicated Appendicitis.
Charles C van Rossem, Marc H F Schreinemacher, Anna A W van Geloven...
https://pubmed.ncbi.nlm.nih.gov/26580850Actively Recruiting
Led by Cedars-Sinai Medical Center · Updated on 2025-04-29
20
Participants Needed
1
Research Sites
8 weeks
Total Duration
Researchers are evaluating an enhanced recovery protocol for adults with complicated appendicitis who undergo laparoscopic appendectomy. The study aims to assess whether discharging patients home on an oral antibiotic regimen for three days after surgery is feasible and safe. Safety will be measured by tracking postoperative infections and readmission rates within 30 days. This pilot study is exploratory and sponsored by Cedars-Sinai Medical Center. Participants will receive oral antibiotics at home for three days instead of staying hospitalized for intravenous antibiotics after their laparoscopic appendectomy. The study includes patients diagnosed with complicated appendicitis, such as perforated, gangrenous, suppurative appendicitis, or iatrogenic appendix perforation, confirmed during surgery. Patients must meet discharge criteria from the post-anesthesia care unit to be eligible. During the study, participants will be monitored for adherence to postoperative instructions and any infectious complications. Researchers will evaluate compliance, safety outcomes, and the need for hospital readmission within 30 days after surgery. The total study period includes follow-up assessments during this 30-day postoperative window to observe recovery and complications.
CONDITIONS
Enhanced Recovery After Surgery (ERAS) for Complicated Appendicitis
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 3 days
Participants undergo laparoscopic appendectomy followed by discharge on an oral antibiotic regimen for 3 days instead of intravenous antibiotics.
1 hospital stay and discharge visit
Duration - 30 days
Participants are followed for 30 days to monitor readmission rates and postoperative infections.
Approximately 1 to 2 follow-up visits
Total: 1 location
1
Cedars-Sinai Medical Center
Los Angeles, California, United States, 90048
Actively Recruiting
L
Laura Sarmiento, CCRP
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Charles C van Rossem, Marc H F Schreinemacher, Anna A W van Geloven...
https://pubmed.ncbi.nlm.nih.gov/26580850Anne Loes van den Boom, Elisabeth M L de Wijkerslooth, Louis J X Giesen...
https://pubmed.ncbi.nlm.nih.gov/36041400Jakob Kleif, Louise Rasmussen, Siv Fonnes...
https://pubmed.ncbi.nlm.nih.gov/28600695